I

(redirected from chronic lymphocytic leukemia)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.

I

Fifth letter of a Nasdaq stock symbol specifying that it is the third preferred bond of the company.

I

1. On a stock transaction table, a symbol indicating that a dividend was paid after a stock split.

2. A symbol appearing next to a bond listed on NASDAQ indicating that the bond is a company's third preferred bond. All NASDAQ listings use a four-letter abbreviation; if the letter "I" follows the abbreviation, this indicates that the security being traded is a third preferred bond.

i

Used in the dividend column of stock transaction tables to indicate that the dividend was paid after a stock dividend or split: Lehigh s.20i.
Mentioned in ?
References in periodicals archive ?
For myeloid leukemia, chronic lymphocytic leukemia, and plasma cell myeloma, no laboratories reported LODs below 0.001%, but a few laboratories enumerated the LOD as 1%.
* Devise corrective measures for pipeline projects by understanding Refractory Chronic Lymphocytic Leukemia (CLL) pipeline depth and focus of Indication therapeutics.
Functional proteomic insights in B-cell chronic lymphocytic leukemia. Expert Rev Proteomics 2017; 14: 137-146.
Catovsky et al., "Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines," Blood, vol.
Refractory Chronic Lymphocytic Leukemia (CLL) - Therapeutics under Investigation by Universities/Institutes 13
Second neoplasms in chronic lymphocytic leukemia: incidence and pathogenesis with emphasis on the role of different therapies.
Relevance of telomere/telomerase system impairment in early stage chronic lymphocytic leukemia. Genes Chromosomes Cancer 2014; 53: 612-621, doi: 10.1002/gcc.
Familial Aspects Of Chronic Lymphocytic Leukemia, Monoclonal B-Cell Lymphocytosis (Mbl), And Related Lymphomas.
Berrebi, "Clinical and Immunologic aspects of B chronic lymphocytic leukemia associated with autoimmune disorders," Israel Medical Association Journal, vol.

Full browser ?